Arax Advisory Partners’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
Arax Advisory Partners's SANA Position: Q3 2026 in Review
Arax Advisory Partners reduced its Sana Biotechnology (SANA) stake by 17% in Q3 2026, selling an estimated $35.1K and leaving 49,475 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2558.
Arax Advisory Partners first reported a position in SANA in Q2 2024 and has held it in 7 quarters since. The position peaked at $586K in Q3 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q3 2026.
- Arax Advisory Partners held 49,475 shares of Sana Biotechnology worth $144K as of Q3 2026.
- Arax Advisory Partners sold 10,083 Sana Biotechnology shares in Q3 2026, an estimated $35.1K.
- Sana Biotechnology made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2558 holding.
- Arax Advisory Partners first reported a position in Sana Biotechnology in Q2 2024 and has held it in 7 quarters since.
- Arax Advisory Partners's Sana Biotechnology position peaked at $586K in Q3 2025.
- 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.